CAR-T Therapy Breakthrough for Glioblastoma

Researchers at King s College London and McMaster University, led by Professor Sheila Singh, have made a groundbreaking discovery in the treatment of Glioblastoma, an aggressive and deadly brain cancer. They have developed a novel CAR-T cell therapy that targets both Glioblastoma cells and the tumor-supporting macrophages by recognizing a protein called GPNMB. In preclinical models, this therapy eliminated detectable tumors and led to long-term disease-free survival. This dual-targeting approach represents a significant paradigm shift, moving beyond solely attacking cancer cells to dismantling the entire tumor-immune ecosystem. While further research is needed before human clinical trials, this study, published in Nature, offers new hope for patients with Glioblastoma, a cancer with a notoriously poor prognosis.